<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>BiG生物创新社 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-09T23:30:02+08:00</updated>
  <subtitle>BiG，Biologics Innovation Group是由致力于从事生物医药领域研究、开发、应用、临床、投资等工作的独立个人，自愿组织的一个专业/非盈利性机构。正式成立于2014年，迄今会员490余人，相继举办20余场行业峰会。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>千人在线！科学家创业会是中国FIC新药的答案么？</title>
    <updated>2021-01-09T22:22:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/U0D3WN-AmwhF4tEaWlfD1A</id>
    <link href="https://mp.weixin.qq.com/s/U0D3WN-AmwhF4tEaWlfD1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>邀丨会前通知，BIO APAC多的是你不知道的事！</title>
    <updated>2021-01-09T22:22:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/lopL_-Xa6OGuEXfKhBBrJg</id>
    <link href="https://mp.weixin.qq.com/s/lopL_-Xa6OGuEXfKhBBrJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>李金泽｜生物学驱动的CD3双抗一期临床开发</title>
    <updated>2021-01-06T17:37:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/urCX9mIH_ce2lXZtwe2fqw</id>
    <link href="https://mp.weixin.qq.com/s/urCX9mIH_ce2lXZtwe2fqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>苏桥生物与非同生物就多个抗体创新生物药签署战略合作协议</title>
    <updated>2021-01-06T17:37:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/vWx9j-M1qxJpxAgcdPCpQQ</id>
    <link href="https://mp.weixin.qq.com/s/vWx9j-M1qxJpxAgcdPCpQQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>简述四种NK细胞疗法耐药机制</title>
    <updated>2021-01-06T16:48:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/6nFw2OvUTJhM7ByZPPtl7g</id>
    <link href="https://mp.weixin.qq.com/s/6nFw2OvUTJhM7ByZPPtl7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>周五直播｜科学家创业工作坊，你可能不知道的N个坑</title>
    <updated>2021-01-06T16:48:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/oJ6tHBEqgQGgW2_aJsJVHw</id>
    <link href="https://mp.weixin.qq.com/s/oJ6tHBEqgQGgW2_aJsJVHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新的策略来定义Tregs！</title>
    <updated>2021-01-04T17:13:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/tybgDJI_AK9PB9ECtfYw_Q</id>
    <link href="https://mp.weixin.qq.com/s/tybgDJI_AK9PB9ECtfYw_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新江湖｜水木未来加入BiG会员机构！</title>
    <updated>2021-01-04T17:13:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/p0X4uhr0Ub8Q-JU8UIdoYQ</id>
    <link href="https://mp.weixin.qq.com/s/p0X4uhr0Ub8Q-JU8UIdoYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再极医药完成近2亿元人民币C轮融资，优选资本领投！</title>
    <updated>2021-01-04T17:13:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/nKTZCJ4puCizSxUig06IzA</id>
    <link href="https://mp.weixin.qq.com/s/nKTZCJ4puCizSxUig06IzA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BiG X 新生巢｜董晨、肖瑞平、钱锋，三对科学创始人携CXO天团来了！</title>
    <updated>2020-12-31T17:54:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/bZBG1y-OnKx8exi6N2ISwQ</id>
    <link href="https://mp.weixin.qq.com/s/bZBG1y-OnKx8exi6N2ISwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CXCR4抗体偶联药物（ADC）如何设计优化？</title>
    <updated>2020-12-31T17:40:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/xLUSOBK9wzVf801RlN2rJQ</id>
    <link href="https://mp.weixin.qq.com/s/xLUSOBK9wzVf801RlN2rJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新江湖｜朱立红、孙正洁、孔令洁、童欣、滕婷婷 加入BiG！</title>
    <updated>2020-12-31T17:40:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/766MpJgAKzUy_V4neWOQ9w</id>
    <link href="https://mp.weixin.qq.com/s/766MpJgAKzUy_V4neWOQ9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最强大脑｜董晨挂帅BiG理事长，肖瑞平/申华琼/崔霁松/Victoria Elegant入选理事会！</title>
    <updated>2020-12-30T08:13:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/hbJ87D7N9jJ_fGTSVg7lBQ</id>
    <link href="https://mp.weixin.qq.com/s/hbJ87D7N9jJ_fGTSVg7lBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>五位大咖谈双抗，靶点、机理、Fc设计、临床开发的关键策略！</title>
    <updated>2020-12-28T19:30:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/SbJ8JpuF-Nzi7DWY9qDevQ</id>
    <link href="https://mp.weixin.qq.com/s/SbJ8JpuF-Nzi7DWY9qDevQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>I/O全新策略！三级淋巴组织构筑的肿瘤免疫微环境</title>
    <updated>2020-12-26T08:00:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/2VLguAfcACKjrakl7j6BLA</id>
    <link href="https://mp.weixin.qq.com/s/2VLguAfcACKjrakl7j6BLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>双抗高阶玩家局！吴辰冰、朱祯平、卢宏韬周二开讲</title>
    <updated>2020-12-26T08:00:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/dw5HX7fzBEwaEI6-mtntsA</id>
    <link href="https://mp.weixin.qq.com/s/dw5HX7fzBEwaEI6-mtntsA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BiG X 新生巢｜大江大河，创业路上的生命科学家们！</title>
    <updated>2020-12-24T18:04:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/CzIxYZ6OpoHEY2nAW3QTuQ</id>
    <link href="https://mp.weixin.qq.com/s/CzIxYZ6OpoHEY2nAW3QTuQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>邀 | “伙力全开”——新药创始人俱乐部2021新春聚会</title>
    <updated>2020-12-24T18:04:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/U6KIVri_URgcyAo_kvVZ1A</id>
    <link href="https://mp.weixin.qq.com/s/U6KIVri_URgcyAo_kvVZ1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>